Skip to content
Research Article Open access CC BY 3.0

Drug Resistance in Mycobacterium tuberculosis Isolates from Northeastern Sudan

S. O. Hassan, M. T. Musa, H. M. Elsheikh, A. M. S. Eleragi, N. S. Saeed

Journal of Advances in Medicine and Medical Research · pp. 424–433 · Published 26 Jun 2012

10.9734/BJMMR/2012/1404

Abstract

The present study intended to determine the drug resistance patterns of Mycobacterium tuberculosis isolates among human new tuberculosis cases from northeastern Sudan using conventional and molecular techniques. Of 100 mycobacterial isolates tested by proportion method, 6% and 2% were identified, respectively, as multi drug resistant-tuberculosis (MDR-TB) and non-multi drug resistant-rifampicin (non-MDR-RIF). A total of 8% was found resistant to rifampicin (RIF), 13% to isoniazid (INH), 34% to streptomycin (STM) and 12% to ethambutol (EMB). Mono-resistant were 0% for RIF, 1% INH, 18% STM and 3% ETH. The remaining 61% isolates were identified as sensitive. Resistance to pyrazinamide was evaluated conventionally for the first time in this country and was found as low as 1%. Molecularly, mutations of MDR-TB, RIF, INH, EMB and STM resistant isolates were detected in 66.7%, 87.5%, 76.9%, 66.7% and 17.6% of corresponding conventional findings, respectively. The genetic mutations were related to the following codons: rpoB 531 (71.4%) and rpoB 526 (28.6%) for RIF, katG 315 (90%) and mabA-inhA-15 (10%) for INH, embB 306 (66.7%) for EMB and rpsL (17.6%) for STM. The study showed that drug resistant tuberculosis increased steadily and provided potentially valuable information on resistant genes circulating in the community. The rapid solving of this problem can benefit both public health and patient management.

Drug resistance Mycobacterium tuberculosis susceptibility Sudan

Cited by 9

Prevalence of Drug-Resistant Tuberculosis in Sudan: A Systematic Review and Meta-Analysis

Khalid Hajissa, Mahfuza Marzan, Mubarak Ibrahim Idriss · Antibiotics · 2021

First-Line Drug Resistance Patterns of <i>Mycobacterium tuberculosis</i> Complex Isolates from Re-Treatment Patients from Sudan

Muatsim Ahmed Mohammed Adam, Hamdan Mustafa Hamdan Ali, Eltahir Awad Gasim Khalil · Journal of Tuberculosis Research · 2016

Resistance Patterns of Mycobacterium tuberculosis to First-Line Anti-TB Drugs in Kaduna State, North-Western Nigeria

Aliyu, M. S., Garba, I., Tijjani, M. B. · UMYU Journal of Microbiology Research (UJMR) · 2020

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan

Monadil H. Ali, Alian A. Alrasheedy, Mohamed Azmi Hassali · Antibiotics · 2019

Tuberculosis drug resistance isolates from pulmonary tuberculosis patients, Kassala State, Sudan

Fatima A. Khalid, Zuhal A. Hamid, M.M. Mukhtar · The International Journal of Mycobacteriology · 2015

Conflict and tuberculosis in Sudan: a 10-year review of the National Tuberculosis Programme, 2004-2014

Sara A. Hassanain, Jeffrey K. Edwards, Emilie Venables · Conflict and Health · 2018

Mycobacterium tuberculosisComplex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan1

Yassir A. Shuaib, Eltahir A.G. Khalil, Lothar H. Wieler · Emerging Infectious Diseases · 2020

Showing 8 of 9 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

9

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.